Covered recipient · General Payments record
JAMES CUELLAR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$11,938.56
- Reported across 151 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $395.70 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $257.15 | 10 |
| Lilly USA, LLC | $138.55 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Lilly USA, LLC | $17.38 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135018192 | CMS |
| Lilly USA, LLC | $121.17 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135041714 | CMS |
| Novo Nordisk Inc | $14.25 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096991655 | CMS |
| Novo Nordisk Inc | $16.60 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096594758 | CMS |
| Novo Nordisk Inc | $16.24 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096951925 | CMS |
| Novo Nordisk Inc | $15.35 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097045113 | CMS |
| Novo Nordisk Inc | $16.57 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096888044 | CMS |
| Novo Nordisk Inc | $14.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096795221 | CMS |
| Novo Nordisk Inc | $6.28 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096671144 | CMS |
| Novo Nordisk Inc | $18.90 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097454741 | CMS |
| Novo Nordisk Inc | $121.86 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097403625 | CMS |
| Novo Nordisk Inc | $17.10 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096680702 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.